Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


05.11.2018

1 BMC Gastroenterol
2 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
2 Gastroenterology
1 Gut
2 Hepatology
1 J Clin Microbiol
1 J Hepatol
1 J Interferon Cytokine Res
3 J Med Virol
6 J Viral Hepat
1 J Virol
1 JAMA
1 Lancet Infect Dis
2 MMWR Morb Mortal Wkly Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Gastroenterol

  1. YANG J, Yan B, Yang L, Li H, et al
    Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study.
    BMC Gastroenterol. 2018;18:161.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  2. CZAJA AJ, Montano-Loza AJ
    Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Oct 28. pii: 10.1007/s10620-018-5351.
    PubMed     Text format     Abstract available

  3. DE MARIA C, Ghidotti I, Grillo F, Giannini EG, et al
    Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Nov 1. pii: 10.1007/s10620-018-5356.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  4. DRIEDGER M, Galanakis C, Doyle MA, Cooper CL, et al
    Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu.
    Eur J Gastroenterol Hepatol. 2018 Oct 30. doi: 10.1097/MEG.0000000000001292.
    PubMed     Text format     Abstract available

  5. LV DD, Wang ML, Chen EQ, Wu DB, et al
    A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection.
    Eur J Gastroenterol Hepatol. 2018 Oct 31. doi: 10.1097/MEG.0000000000001299.
    PubMed     Text format     Abstract available

  6. SHAHID M, Idrees M, Butt AM, Raza SM, et al
    Hepatitis C and G virus coinfection in Punjab, Pakistan: incidence and its correlation analysis with clinical data.
    Eur J Gastroenterol Hepatol. 2018 Oct 31. doi: 10.1097/MEG.0000000000001302.
    PubMed     Text format     Abstract available


    Gastroenterology

  7. IOANNOU GN, Feld JJ
    What are the Benefits of a Sustained Virologic Response to Direct-acting Antiviral Therapy for HCV Infection?
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35166.
    PubMed     Text format     Abstract available

  8. PERRY I, Patel D
    Hemoptysis: Call the Gastroenterologist?
    Gastroenterology. 2018;155:e1-e2.
    PubMed     Text format    


    Gut

  9. WEDEMEYER H, Negro F
    Devil hepatitis D: an orphan disease or largely underdiagnosed?
    Gut. 2018 Oct 27. pii: gutjnl-2018-317403. doi: 10.1136/gutjnl-2018-317403.
    PubMed     Text format    


    Hepatology

  10. DAVIS C, Mgomella GS, Filipe ADS, Frost EH, et al
    New highly diverse hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments.
    Hepatology. 2018 Nov 2. doi: 10.1002/hep.30342.
    PubMed     Text format     Abstract available

  11. WANG YH, Chuang YH, Wu CF, Jan MC, et al
    Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30339.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  12. AKUTA N, Suzuki F, Sezaki H, Kobayashi M, et al
    The complex association of virus- and host-related factors with HCC rate following HCV clearance.
    J Clin Microbiol. 2018 Oct 31. pii: JCM.01463-18. doi: 10.1128/JCM.01463.
    PubMed     Text format     Abstract available


    J Hepatol

  13. JENNY I, Gregory JD, Beth C, Philip C, et al
    Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    J Hepatol. 2018 Oct 24. pii: S0168-8278(18)32494.
    PubMed     Text format     Abstract available


    J Interferon Cytokine Res

  14. WANG JW, Wang JW, Zhang J, Wu CS, et al
    Decreased Methylation of IFNAR Gene Promoter from Peripheral Blood Mononuclear Cells Is Associated with Oxidative Stress in Chronic Hepatitis B.
    J Interferon Cytokine Res. 2018 Oct 31. doi: 10.1089/jir.2018.0068.
    PubMed     Text format     Abstract available


    J Med Virol

  15. KOC OM, Robaeys G, Yildirim B, Posthouwer D, et al
    The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection.
    J Med Virol. 2018 Nov 1. doi: 10.1002/jmv.25353.
    PubMed     Text format     Abstract available

  16. DA COSTA MARQUES BORGES LF, Zalis MG, Santoro-Lopes G, Varella RB, et al
    Hepatitis C virus (HCV) genotypes in hemodialysis patients in Angola.
    J Med Virol. 2018 Nov 1. doi: 10.1002/jmv.25354.
    PubMed     Text format     Abstract available

  17. NAGAOKI Y, Imamura M, Nisihda Y, Daijo K, et al
    The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma; comparison with interferon-based therapy.
    J Med Virol. 2018 Nov 1. doi: 10.1002/jmv.25352.
    PubMed     Text format     Abstract available


    J Viral Hepat

  18. BRICHLER S, Nahon P, Zoulim F, Layese R, et al
    Non-virological factors are drivers of Hepatocellular Carcinoma in virosuppressed Hepatitis B cirrhosis: results of ANRS CO12 CirVir cohort.
    J Viral Hepat. 2018 Oct 31. doi: 10.1111/jvh.13029.
    PubMed     Text format     Abstract available

  19. WU DB, Jiang W, Wang YH, Chen B, et al
    Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in southwest China: real-world experience of a retrospective study.
    J Viral Hepat. 2018 Oct 31. doi: 10.1111/jvh.13033.
    PubMed     Text format     Abstract available

  20. DONG XQ, Wu Z, Zhao H, Wang GQ, et al
    Evaluation and Comparison of Thirty Non-invasive Models for Diagnosing Liver Fibrosis in Chinese Hepatitis B Patients.
    J Viral Hepat. 2018 Oct 31. doi: 10.1111/jvh.13031.
    PubMed     Text format     Abstract available

  21. WU Z, Dong X, Wang G, Zhao H, et al
    Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
    J Viral Hepat. 2018 Oct 31. doi: 10.1111/jvh.13030.
    PubMed     Text format     Abstract available

  22. ORR C, Aartun J, Masur H, Kottilil S, et al
    Characterization of Changes in Intrahepatic Immune Cell Populations During HCV Treatment with Sofosbuvir and Ribavirin.
    J Viral Hepat. 2018 Nov 1. doi: 10.1111/jvh.13034.
    PubMed     Text format     Abstract available

  23. ABDEL GHAFFAR TY, Naghi SE, Gawad MA, Helmy S, et al
    Safety and Efficacy of Combined Sofosbuvir/Daclatasvir Treatment of Children and Adolescents with Chronic Hepatitis C Genotype 4.
    J Viral Hepat. 2018 Oct 31. doi: 10.1111/jvh.13032.
    PubMed     Text format     Abstract available


    J Virol

  24. PHAM HT, Nguyen TTT, Nguyen LP, Han SS, et al
    Hepatitis C virus downregulates ubiquitin conjugating enzyme E2S expression to prevent proteasomal degradation of NS5A, leading to host cells more sensitive to DNA damage.
    J Virol. 2018 Oct 31. pii: JVI.01240-18. doi: 10.1128/JVI.01240.
    PubMed     Text format     Abstract available


    JAMA

  25. TRUSHEIM MR, Cassidy WM, Bach PB
    Alternative State-Level Financing for Hepatitis C Treatment-The "Netflix Model".
    JAMA. 2018 Oct 29. pii: 2712366. doi: 10.1001/jama.2018.15782.
    PubMed     Text format    


    Lancet Infect Dis

  26. STONE J, Fraser H, Lim AG, Walker JG, et al
    Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Lancet Infect Dis. 2018 Oct 29. pii: S1473-3099(18)30469.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  27. FOSTER M, Ramachandran S, Myatt K, Donovan D, et al
    Hepatitis A Virus Outbreaks Associated with Drug Use and Homelessness - California, Kentucky, Michigan, and Utah, 2017.
    MMWR Morb Mortal Wkly Rep. 2018;67:1208-1210.
    PubMed     Text format     Abstract available

  28. NELSON NP, Link-Gelles R, Hofmeister MG, Romero JR, et al
    Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
    MMWR Morb Mortal Wkly Rep. 2018;67:1216-1220.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: